Migraine: Familial migraine with aura is associated with a mutation in the TRESK potassium channel.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

1. Migraine is a dysfunction of neuronal potassium ion channels.Frontiers in neurology · 2025
   Review
2. Shortened Spadin Analogs Display Better TREK-1 Inhibition,Frontiers in pharmacology · 2017
   Article
3. Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18.Drug design, development and therapy · 2014
   Article
4. Studies on the pathophysiology and genetic basis of migraine.Current genomics · 2013
   Article
5. The biology of the glutamatergic system and potential role in migraine.International journal of biomedical science : IJBS · 2013
   Article

Corrections and comments

• Comment on
  A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.